UPCC 07422 Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients

Age
99 years or below
Gender
All
participants needed
72
Location
1
UPCC 07422 Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients

Brief description of study

Please refer to Protocol Section 2.0, Study Objectives. Please refer to Protocol Sections 8.2, Primary Endpoints. Please refer to Protocol Sections 8.3, Secondary Endpoints.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All
Updated on 11 Oct 2024. Study ID: 851615
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research